Brazilian Position Statement for Familial Chylomicronemia Syndrome-2023

Abstract

(iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, Funding of continuing medical education activities, including travel, accommodation and registration in conferences and Any economically relevant equity interest in companies in the healthcare or education industry or in any companies competing